Compare CYTK & LLYVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | LLYVA |
|---|---|---|
| Founded | 1997 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Broadcasting |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7B | 9.2B |
| IPO Year | 2004 | 2025 |
| Metric | CYTK | LLYVA |
|---|---|---|
| Price | $72.72 | $95.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 19 | 0 |
| Target Price | ★ $89.26 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 93.1K |
| Earning Date | 05-05-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | $13,368,000.00 | ★ $381,951,000.00 |
| Revenue This Year | $7.37 | N/A |
| Revenue Next Year | $310.19 | $5.52 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 12.18 |
| 52 Week Low | $47.22 | $74.38 |
| 52 Week High | $88.31 | $106.06 |
| Indicator | CYTK | LLYVA |
|---|---|---|
| Relative Strength Index (RSI) | 42.80 | 43.69 |
| Support Level | $73.34 | $93.31 |
| Resistance Level | $79.73 | $99.16 |
| Average True Range (ATR) | 2.22 | 2.32 |
| MACD | -0.38 | -0.61 |
| Stochastic Oscillator | 39.09 | 5.35 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Liberty Live Holdings Inc consists of its ownership in Live Nation, its wholly owned subsidiary Quint and other minority investments. Quint is a provider of premium sports and entertainment experiences. Through exclusive rights agreements with sports leagues, event organizers, and governing bodies, Quint designs, develops, and sells official ticket-inclusive hospitality and single to multi-day experiential packages that may include on or off-site experiences, transportation, and hotel accommodations, with involvement of Quint personnel throughout the multi-day experiences. Live Nation is one of the live entertainment companies in the world, and the producer of live music concerts in the world, based on total fans that attend Live Nation events as compared to events of other promoters.